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Abstract

Conventional STR typing, commonly used in forensics for human identification, poses a problem
in criminal cases and paternity disputes involving monozygotic (MZ) twins because they share
identical DNA sequences. To date, no routine method is available in forensics to differentiate
between individuals of MZ pairs. Recently, epigenetic methods measuring differential DNA
methylation patterns have been applied to MZ twin differentiation. In this study, we investigated
the potential to identify MZ twins using a previously identified DNA methylation site in
chromosome 3, cg18562578, in a sample of 129 MZ and 37 dizygotic (DZ) twin pairs. We used
bisulfite converted saliva DNA and a 2-step methylation-specific qPCR method to determine DNA
methylation at this site. We investigated differences between MZ and DZ twins as well as within
MZ twin pair differences. We found that MZ and DZ twin pair differences were not statistically
significant (0.39±0.29 vs 0.46±0.41, p-value=0.38) suggesting that DNA methylation at this site
in the genome is not directly related to genetics. In addition, DNA methylation differences between
MZ twins in a pair were found to be statistically significant (0.39±0.30 vs 0.78±0.29, pvalue=0.00001). However, for 22% of the MZ pairs with DNA methylation differences below 0.1,
there is no statistically significant difference to allow for discrimination. While more research
needs to be conducted, this study highlights the potential of DNA methylation markers in the
discrimination of MZ twins using saliva DNA
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Introduction and Literature Review

Epigenetics
Epigenetics is the study of mitotically heritable alterations that affect gene expression and are not
a part of the DNA sequence. It is the study of the various changes within organisms with
distinguished cells, expression of genes, and the mitotic inheritance of gene expression patterns
(Deans & Maggert, 2015). Overall, chemical modifications to the DNA sequences together make
up the epigenome, which is altered by physiological events such as nutrition, age, and exposure to
infectious and toxic substances (Beck et al., 2012). In contrast to the genome, which is the same
in all cells of an organism, epigenomes are the direct result of a gradual commitment of cellular
lineages to the more constrained gene expression patterns throughout the process of development
(Maunakea, Chepelev, & Zhao, 2010).

Epigenetic modifications include DNA methylation, chromatin structure modifications, and noncoding RNAs (Hamilton, 2011). DNA methylation is the most extensively studied epigenetic
modification (Richards, Patel, Stevenson, & Harbison, 2018). DNA methylation involves the
covalent binding of a methyl group to a cytosine that precedes a guanine nucleotide. Covalent
bonding of the methyl group to the cytosine nucleotide is facilitated by DNA methyltransferases
(DNMT) (Hamilton, 2011; Jin, Li, & Robertson, 2011). In mammalian DNA, there are two
families of DNA methyltransferases that are functionally and structurally distinct. The DNMT3
family is responsible for the initial CpG methylation pattern, while the DNMT1 family maintains
the original methylation pattern during the replication and repair of the chromosomes (Cheng &
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Blumenthal, 2008). DNA methyltransferases are essential to mammalian development and are
critical in the maintenance of DNA methylation patterns as well as ensuring stability within the
genome. Without the expression of DNMT's, there can be detrimental effects including cancer
(Dhe-Paganon, Syeda, & Park, 2011; Jin & Robertson, 2013).

Alongside DNA methylation, chromatin modifications, and non-coding RNAs are epigenetic
marks that regulate transcription (Moore, Le, & Fan, 2013). Chromatin modifications involve
structural changes such as the addition or removal of chemical groups to histone proteins that
package and assemble DNA into nucleosomes (Costa, 2008; Henikoff & Smith, 2015; Kouzarides,
2007). Chromatin modifications also help to regulate gene expression by altering the packaging of
the DNA. It is facilitated by enzymatic, post-translational modifications of histones, and take place
in the form of acetylation, phosphorylation, ubiquitination, and methylation (Barter, Bui, &
Young, 2012; Edwards, Yarychkivska, Boulard, & Bestor, 2017; Kouzarides, 2007). Evidence has
shown that most epigenetic mechanisms involving gene expression control are regulated by noncoding RNAs. Non-coding RNAs such as microRNAs (miRNA) are single-stranded, short in
length with only 20-23 nucleotides, and regulate the expression of genes post-transcriptionally by
targeting mRNAs for degradation (Barter et al., 2012; Wang, Wu, & Claret, 2017).

For a substantial amount of time, it was believed that epigenetic marks, specifically DNA
methylation patterns, were generated during embryogenesis and remained fixed throughout an
individual's life. However, recently, it was discovered that environmental signals contribute to the
DNA methylation patterns outside of embryogenesis and cell differentiation (Szyf & Bick, 2013).
DNA methylation is modified by multiple factors, it represents a combination of genetic,
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environmental and behavioral interactions. Overall, epigenetic modifications mediate
development, differentiation, susceptibility to disease, and can significantly contribute to one’s
phenotype (Loscalzo & Handy, 2014; Whitelaw & Whitelaw, 2006).

Epigenetics in Forensic Science
The field of forensic epigenetics is relatively new, but promising. It involves the application of
epigenetics to forensic science for the purpose of solving forensic cases. Epigenetics incorporates
a second layer of genetic information found within the genome that is responsible for the regulation
and control of information from the genome to the proteome (Williams, 2018). From all epigenetic
marks, forensic epigenetics has focused on DNA methylation marks more specifically. To date,
some of the applications of epigenetics in forensic science involve 5'—C—phosphate—G—3’
(CpG) marker discovery, prediction modelling, and targeted DNA methylation analysis involving
the identification of tissue cell-type sources of DNA evidence, age estimation, sex determination,
and differentiation between monozygotic (MZ) twins (Vidaki & Kayser, 2018)

Sex Determination

The first introduction of differential DNA methylation analysis into forensics was for the
determination of an individual's sex. Naito et al., (1993) positively determined sex by investigating
the methylation status of the X chromosomes in a female sample. In the study, the
hypermethylation present on the active X chromosome prevented enzymatic digestion of the HpaII
restriction enzyme while the hypomethylated, inactive X chromosome was digested into smaller
fragments (Naito, Dewa, Yamanouchi, Takagi, & Kominami, 1993). As a result, this showed that
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the inactive X chromosome, only present in females, could be tested and used for sex typing.
Another study used the hypomethylation status of the DXZ4 macrosatellite by analyzing regions
of genomic DNA where there are statistically significant DNA methylation levels that are different
within the population of cells of two samples being compared (Zhang et al., 2013).

Body Fluid Identification
Differences in DNA methylation levels within different biological fluids is due to cell type
qualitative and quantitative differences in their gene expression patterns (Gibney & Nolan, 2010;
Stewart, Evans, Bexon, Van Der Meer, & Williams, 2015). Epigenetic forensic studies involving
body fluid identification aim to overcome the limitations of routine chemical detection methods
that cannot distinguish between different bodily fluids. With the use of genome-wide screening,
and marker-specific DNA methylation analysis, downstream applications have been used for the
identification of different tissues (Forat et al., 2016; Fu et al., 2015; Park et al., 2014).

Multiple studies have shown that there are varying DNA methylation patterns in forensically
relevant biofluids including venous blood, menstrual blood, vaginal fluid, saliva, and sperm (Forat
et al., 2016; Fu et al., 2015; Langie et al., 2016; Madi, Balamurugan, Bombardi, Duncan, &
McCord, 2012; Thomas et al., 2018). Madi et al., (2011) investigated DNA methylation differences
in blood, saliva, semen, and epithelial tissue. The study involved the use of four epigenetic markers
found to display differential methylation patterns between these sources. The markers at loci,
ZC3H12D, and FGF7 differentiated sperm from the other sources. C20orf117 differentiated blood
from other sources, and BCAS4 differentiated saliva from the other sources (Madi et al., 2012).
Fu et al., (2015) also investigated tissue-specific differentially methylated regions within genes
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BIK, CYTH4, GAS2L1, MDFI and OSM in venous blood, saliva, semen, menstrual blood, and
vaginal fluid. The identified markers were evaluated within 40 body fluid samples and showed
success in discriminating between the five bodily fluids with high sensitivity and specificity (Fu
et al., 2015). Two genome-wide screenings using the Illumina HumanMethylation BeadChips 27
and 450K platforms, have been used to identified DNA methylation sites that are tissue specific,
Forat et al., 2016 identified 150 loci that showed differential DNA methylation patterns in
menstrual blood, vaginal blood, sperm, saliva, and venous blood (Forat et al., 2016).

There is also evidence of variations at methylated sites in blood and saliva DNA of the same
individuals. Langie et al., (2016) performed methylation profiling using the Illumina Methylation
450K BeadChip platform to investigate respiratory allergies in ten individuals. The data generated
showed that there were 485 and 437 differentially methylated sites in saliva and blood,
respectively, with 216 shared sites in common (Langie et al., 2016). Furthermore, in a study with
41 individuals, four CpG sites were investigated within the BDNF IV gene promoter in which DNA
methylation levels were found to be significantly hypermethylated within the saliva, but not in
blood (Thomas et al., 2018).

There is an understanding that DNA methylation patterns change due to endogenous and
exogenous factors such as environmental conditions and disease. In a study, three environmental
influences (room temperature, humidity, and the outdoors) and 12 tumors were evaluated for their
effect on DNA methylation patterns. Approximately 100 samples per each biological source
(venous blood, menstrual blood, vaginal fluid, saliva, and sperm) were evaluated under each
environmental influence. The data generated showed that environmental influences affected DNA
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methylation patterns when exposed to humidity and the outdoors. It was also seen that tumors
evaluated in vaginal fluid and sperm significantly affected the DNA methylation patterns (Forat et
al., 2016). The use of DNA methylation for bodily fluid identification is seen as a more practical
approach that can be used as an alternative to current forensic techniques. Currently, body fluid
identification in forensic science involve a variety catalytic tests for specific bodily fluids and are
detected by a color change (An, Shin, & Lee, 2012). Although useful, the current forensic bodily
fluid techniques have limitations. If a mixture is encountered, the sample would have to be run for
each proposed bodily fluid test, which requires excess use of the available sample. In addition, the
catalytic, protein and enzymatic based testing methods results may be compromised due to the
potential of sample degradation, which is a factor of forensic trace-type samples. Therefore, DNA
methylation is a more practical approach that can be used as an alternative in which less sample
would be required, and the detection power of multiple bodily fluid sources in one reaction would
be possible (Holtkötter, Schwender, Wiegand, Peiffer, & Vennemann, 2018).

Age Estimation
Aging is a steady and gradual process, which can be influenced by one's lifestyle, environment,
heredity, and disease. The consequences of aging result in molecular changes such as telomere
shortening, and changes in the expression of genes (Jones, Goodman, & Kobor, 2015). To date,
epigenetic patterns have been recognized as being able to change over an individual's lifetime and
is a crucial component of the aging process (Jones et al., 2015; Jung, Shin, & Lee, 2017). The
application of epigenetics for forensic age estimation has become very useful in unknown persons
cases and can provide important leads within police investigations (Zubakov et al., 2016). DNA

7
methylation markers serve as a promising approach for age prediction, and many studies show its
potential using blood as the DNA source.

Multiple studies have identified DNA methylation marks that correlate with age. Researchers used
genome-wide methylation profiling of DNA methylation marks to identify biomarkers that showed
a high correlation to age in 226 individuals ranging from ages 18 to 65 years. DNA methylation
data of six tested CpG loci within the genes SST, CNGA3, KLF14, TSSK6, TBR1, and SLC12A5
were selected to create an age prediction model. In this study, the DNA methylation data and age
information from 113 samples were used to create the age predictive function while 113 remaining
samples were used as an experimental setup to determine the age-predictive accuracy, which was
found to be 94.5% with only an absolute deviation of ±3 years (Hong et al., 2017). In another
study, Alghanim et al., (2017) studied 27 CpG sites that associate with genes SCGN, DLX5, and
KLF4. Seventy-two blood samples, along with 91 saliva samples were used from individuals
ranging from the ages of 5 to 73 years. Of the three genetic loci investigated, markers within the
SCGN and KLF4 produced data showing a linear correlation with chronological age. Also
prediction modeling using the data set determined that there was a mean absolute deviation in age
of ±5.8 years and ±6.2 years for a single and dual-locus model, respectively, showing that DNA
methylation markers tested in the genes SCGN and KLF4 can be used as potential age estimators
(Alghanim et al., 2017). Another study investigated 88 CpG sites near 80 genes among 34
monozygotic twin pairs in which the cytosine methylation was significantly correlated with age
(Bocklandt et al., 2011). Further validation of three selected CpG sites in this study also showed a
linear correlation of age over a range of five decades in a general population cohort of 60
individuals between the ages 18 and 70 (Bocklandt et al., 2011). Another study investigated the
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predictive power of 75 statistically significant age estimating DNA methylation markers associated
with the genes DUSP27, ORAOV1, RXRA, ELOVL2, and FHL2 were tested in the blood of 52
individuals ranging from the ages of 4 to 82 years. It was found that DNA methylation markers
outperform that of mRNA, T-cell specific DNA rearrangements, and telomere length (Zubakov et
al., 2016). Overall, DNA methylation has been used to study and identify markers that correlate
with age, showing the potential of epigenetic markers in estimating an individual's age.

Monozygotic Twin Differentiation
Differentiating between MZ pairs is a challenge within criminal investigations. The goal of
identifying the donor of forensic evidence left behind at a crime scene involves molecular methods
that target regions of the genomic DNA that are unique to every individual, except when MZ twins
are involved (Copenhaver et al., 2018; Saad, 2005). DNA typing involves targeting the short
tandem repeat (STR) regions, which are abundant throughout the genome and are highly
polymorphic, making it a promising approach in forensic identity testing (Schneider, 1997).
Identical twins are expected to generate the same short tandem repeat profile since they share an
identical DNA sequence (Budowle, 2014). Because of this issue, there has been scrutiny about the
inability to genetically distinguish between MZ, and the capabilities of genetic testing and its
probative value has been questioned (Krawczak, Budowle, Weber-Lehmann, & Rolf, 2018).
Methods other than routine STR profiling, such as next-generation sequencing (NGS) and DNA
methylation studies, are the most applicable to obtaining DNA sequence information that supports
the goal of differentiating between MZ (Stewart et al., 2015). Next-generation sequencing is a
technique that allows for the complete sequencing of the human genome in a short time frame with
the possibility of targeted sequencing of coding and non-coding regions or a small number of genes
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(Behjati & Tarpey, 2013). In the case of MZ twins, NGS technology can aid in identifying rare
single nucleotide polymorphisms (SNP), if any, based on mutational analysis, but the use of DNA
methylation is a more promising approach. DNA methylation patterns are unique to an individual
due to the process of aging, environmental factor exposures, one’s health and lifestyle (Park, Woo,
Kim, & Kim, 2017).

A limited amount of research has gone into twin differentiation using DNA methylation-based
methods. Five studies have shown the potential in differentiating between MZ twins by performing
methods involving DNA modification-based mapping of methylated cytosines, which proved that
there are, in fact, epigenetic differences between MZ twins (Marqueta-Gracia et al., 2018; Stewart
et al., 2015; Vidaki et al., 2017, 2018; Xu et al., 2015). Detection of DNA methylation differences
using the Illumina Infinium HumanMethylation27 BeadChip array in a study involving blood
samples from 22 MZ twin pairs showed that CpG DNA methylation profiling could be an ideal
method for the individual identification of MZ twins. It was discovered that 92 CpG sites were
significant amongst 22 twin pairs out of the 27,578 CpG sites screened within the epigenome (Li,
Zhao, Zhang, Zhang, & Hou, 2013). Genome-wide screening using the Illumina Infinium Human
Methylation 450K BeadChip array was also completed in two other studies, one involving the
analysis in DNA from blood of 10 MZ twin pairs. There were 19 to 111 twin differentially
methylated sites identified amongst twin pairs with twin-to-twin differences greater than 0.3. The
top three markers across all twin pairs were selected and validated using a methylation-specific
quantitative polymerase chain reaction (qPCR) where 67%

of the twins generated DNA

methylation differences greater than 0.1 (Vidaki et al., 2017). The 450K BeadChip array platform
has also been used for detecting DNA methylation differences in a twin pair using saliva based
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DNA. Epigenome-wide screening revealed 25 twin differentially methylated markers showing
twin-to-twin difference greater than 0.5. Twenty-two markers were then selected for validation
using a methylation-specific qPCR where the method revealed that six markers showed DNA
methylation differences greater than 0.1, seven markers had DNA methylation differences less
than 0.1, and nine did not correlate to the initial genome screening array analysis (Vidaki et al.,
2018).

A DNA methylation site specific targeting technique for MZ twin differentiation is high resolution
melting (HRM) qPCR, a dye-based chemistry assay that involves the detection of the fluorescence
emitted during the amplification cycles of double stranded DNA followed by a melt curve cycle
where a gradual increase in temperature ultimately warrants complete dissociation of the amplified
PCR products (Marqueta-Gracia et al., 2018). This technique has shown evidence of MZ twin pair
discrimination in a study using two markers; Alu-E2F3 and Alu-SP, targeting 2 and 17 CpGs
respectively in 5 MZ twin pairs using buccal swab DNA. Significant melting temperature
differences were detected in all MZ pairs when targeting 2 CpGs, but only four MZ pairs showed
differences when targeting 17 CpGs (Stewart et al., 2015). Used in another study in which saliva
DNA from 18 MZ twin pairs was tested, investigating six differentially methylated regions, four
showed significance in the power of discrimination in 44% of the studied twins (Marqueta-Gracia
et al., 2018). This suggests that HRM is a practical method to discriminate between the DNA
methylation pattern of MZ twins. Although qPCR can overcome problems associated with PCR
bias, interpretation can become complicated if too many CpG sites are present within the amplified
DNA fragment. It then becomes more practical for analysis of a low number of CpG sites (Umer
& Herceg, 2013).

11

Pyrosequencing methodology has also been used to investigate DNA methylation differences in
MZ twins. A study using pyrosequencing showed that LINE-1 DNA methylation status from blood
and buccal DNA samples in 15 of 119 MZ twin pairs tested were differentiated according to the
differences in CpG DNA methylation levels (Xu et al., 2015). It has been found that human DNA
methylation predominantly occurs within repetitive regions that are abundant in dormant
transposable elements (Lisanti et al., 2013). These DNA methylation patterns occur across the 28
million CpG sites within the genome and are said to be 70 to 80% methylated with the DNA
methylation information being present on both the sense and antisense strands (Jeltsch, Broche, &
Bashtrykov, 2018). Another approach using pyrosequencing involved the analysis of the
methylation patterns of six tumor suppressor genes, ATM, BRCA1, BRCA2, MLH1, RAD51V, and
TP53 in body cells of a MZ female twin pair discordant for childhood leukemia and secondary
thyroid carcinoma. The results showed that there was a 9% DNA methylation difference between
the twins. It was also found that there was a constitutive promoter DNA hypermethylation of
BRCA1 in the healthy cells of the affected twin, but such methylation status was not found in the
healthy twin (Galetzka et al., 2012).

Currently, routine forensic casework involves STR profiling of highly polymorphic regions of the
DNA. It is only beneficial when individuals are not genetically identical, which is the case for MZ
twins. This poses a huge limitation leading to dead-ends within forensic cases and may result in
prime suspects being set free (Vidaki et al., 2017). With no method in place to discriminate
between MZ twins attention has been placed on the use of epigenetics applied to forensic science
to show differences in MZ twins. It is still unclear which specific markers can be successful in the
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individual identification of MZ twins and more research is needed (Kader & Ghai, 2015; Richards
et al., 2018). In addition, it would require a methodology that is sensitive and has high
discriminatory power that can be easily implemented in forensic laboratories (Walsh, 2004).
Epigenetic markers of specific tissues could have extreme forensic relevance and the potential to
aid in MZ twin differentiation (Sabeeha & Hasnain, 2019).
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Purpose and Goal of Study

The limitations of forensic science techniques in differentiating between MZ twins have posed a
problem in criminal cases and paternity disputes involving twins. In 1999, a rape case involving a
young woman was never solved, because when the DNA profile from the semen evidence
eventually matched an individual in 2004, it was found that he had an identical twin brother. This
then made it impossible for both brothers to be jailed as none took responsibility and caused the
case to remain unsolved (Jobling, 2013). In 2007, a woman gave birth to a child after relationships
with MZ twin brothers. Identity testing showed that there was a 99.9% probability that both
brothers were likely to be the father. With no other techniques available, circumstantial evidence
was used to rule one of the brothers as the father (Krawczak et al., 2018). As a result of the long
term inability to individually identify MZ twins, focus has been placed on research using DNA
methylation.

The goals of this research were to identify and select a DNA methylation marker that can
potentially differentiate MZ twins, and design and optimize a two-step PCR method that would be
practical, cost effective in accommodating forensic trace-type samples. In order to be successful
in such research, a large sample set is required which is important for the discovery of small
epigenetic differences which are expected to exist between MZ twins (Bell & Spector, 2011; Kratz,
Edelman, Wang, Meltzer, & Greene, 2014).

Here, we selected a DNA methylation marker previously identified in a genome-wide screening.
The study identified 25 significant twin differentially methylated markers with differences greater
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0.5. in a twin pair from saliva, cigarette butt, and buccal DNA (Vidaki et al., 2018). From this set,
we selected the marker that had the highest DNA methylation differences between the twin pair
across the three DNA sources. The selected marker was incorporated into a 2-step PCR assay
design using a previously described method that can accommodate the typical low yield of
forensically relevant samples (Vidaki et al., 2017).
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Materials and Methods

Study Sample
Twin samples were provided by the Department of Psychology, University of Novi Sad, Novi Sad,
Republic of Serbia. All volunteers had been recruited as part of a twin study on behavior and drug
use as approved by the University of Novi Sad’s Institutional Ethics Committee. Three hundred
thirty-two previously extracted MZ and dizygotic (DZ) twin genomic DNA samples from human
buccal swabs were anonymously processed with unique identifiers throughout the course of the
research. Zygosity was confirmed at John Jay College by Dr Prinz’s research group. No subject
information was shared by the researchers that collected the samples.

DNA Quantitation
Genomic DNA samples were quantified with a Thermo Scientific™, NanoDrop™ 2000/2000c
Spectrophotometer, using 1.0 μL of the sample. Ultraviolet absorbance data from the 260/280
ratios were used to determine the DNA quantity and recorded as the nanogram per microliter
concentration across the sample set.

Bisulfite Conversion
1.0 microgram of DNA was aliquoted for each quantified DNA sample and processed for bisulfite
treatment using the Zymo Research, EZ-96 DNA Methylation-Gold™Kit (Catalog, D5008). This
converted the DNA template's unmethylated cytosine nucleotides at CpG sites to a uracil base,
leaving the methylated cytosines unchanged (Figure 1). We carried out a subsequent
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desulphonation of the converted, uracil base template (uracilsulphonate). The bisulfite conversion
process using the EZ-96 DNA Methylation-Gold™Kit was completed by following the
manufacturer’s protocol. Briefly, a combination of 1.0 microgram of genomic DNA in a volume
of 20 microliters (µL) of water, 130 µL of the provided CT Conversion Reagent were mixed in a
well of a 96-well thermal cycler plate. The reaction plate was sealed and incubated for the
conversion reaction: 98°C for 10 minutes, 64°C for 2.5 hours. 600 μL of M-Binding Buffer were
added to a well respective to each sample of a Zymo-Spin Binding Plate (contains a filter and
collection plate, stacked). The samples (approximately 150 μL) were added to the Zymo-Spin plate
and mixed with the M-Binding buffer. The plate was sealed, and this was followed by
centrifugation at 3,000xg for a total of 5 minutes. After centrifugation, from the collection plate
portion of the Zymo-Spin plate, the flow-through was discarded, and the collection plate placed
back under the filter plate. 400 μL of M-Wash Buffer was then added to the plate, and centrifuged
for 5 minutes at 3,000xg. The flow-through was discarded from the collection plate, and 200 μL
of M-Desulphonation Buffer was added to the filter plate. The Zymo-Spin plate was left to incubate
at room temperature for 15 minutes. Following the incubation, a centrifugation step of 5 minutes
at 3,000xg was completed. The flow-through was discarded from the collection plate followed by
two final wash steps with the first requiring 400 μL of the M-Wash Buffer and centrifugation of
the plate at 3,000xg for 5 minutes. The second wash was completed by adding another 400 μL of
M-Wash Buffer followed by centrifugation at 3,000xg for 10 minutes. After each centrifugation
step, the flow-through was discarded from the collection plate. The purified, bisulfite converted
DNA was eluted off the filter column plate into a clean 96-well plate (provided in the kit) by the
addition of 50 μL of M-Elution Buffer. The plate was incubated at room temperature to allow for
maximum recovery of DNA for 5 minutes. The plate was then centrifuged for 3 minutes at 3,000xg
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to elute the DNA into the elution plate. The purified converted DNA was then stored at -20°C
until needed for further processing.

Figure 1: Schematic of genomic DNA (gDNA) template processed for bisulfite conversion
and nested PCR followed by methylation-specific and methylated-independent quantitative
PCR (qPCR). (A) Double-stranded genomic DNA with methylated cytosines of the CpG
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dinucleotide indicated by "Ⓜ” before bisulfite conversion. (B) Template gDNA post bisulfite
conversion with the methylated cytosine of the CpG site, unchanged (indicated by an arrow) and
the unmethylated cytosines converted to a uracil base. Strand separation indicates the loss of
complementarity as a result of the reaction. (C) Nested, methylation-independent PCR of the
bisulfite conversion reaction products with custom-designed primers where the uracil is recognized
as thymine nucleotides. (D-E) qPCR reactions for the methylation-specific and methylatedindependent primer sets, respectively.

CpG Marker Selection and Primer Design
A DNA methylation marker, cg18562578, was selected based on research by Vidaki et al., (2018).
In that research, 25 epigenetic markers in DNA from buccal, saliva, and cigarette butts were
selected from a genome-wide screening using the Illumina Infinium Human Methylation 450K
BeadChip array. Twenty-two markers were further validated using a methylation-specific qPCR
where marker cg18562578 had the highest DNA methylation differences amongst the studied twin
pairs for the three DNA sources. A quantification method to determine DNA methylation at this
CpG site was designed following a method developed by Vidaki et al., (2017). The method
involves two PCR reactions, a nested PCR followed by a qPCR specific to quantify only
methylated DNA at this position (Figure 2).
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Nested PCR
The initial PCR reaction, a nested PCR, served to create an amplicon that flanks the region of
interest. Primers for the nested PCR were designed by locating the CpG locus ID within the online
University of California Santa Cruz Genome Browser under the Genome Reference Consortium
Human Build 37/ human genome 19 (GRCh37/hg19). The genomic position of locus cg18562578,
chr3:55,517,854, found within the intronic region of the WNT5A gene was located and a 1,000
base pair (bp) region of DNA sequences incorporating the CpG site of interest was selected. This
1,000 bp sequence was used to virtually bisulfite convert in the online Urogene, Meth Primer
software. The converted DNA sequence was then used as the new template for selecting a region
of sequences unbiased of methylation status to design primers.

Forward and reverse primer sequences were designed with a length between 18-25 bases and were
checked for specificity to the flanking region of the cg18562578 marker using the BiSearch, ePCR
Primer Design and Search Tool (Table 1). The primer set was virtually confirmed to produce one
specific amplicon and selected for use in the nested PCR process, using the BiSearch, ePCR
Primer Design, and Search Tool. The design of the selected primer sequences was completed by
ordering the specific forward and reverse sequences through the online Integrated DNA
Technologies (IDT) site.
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Table 1: Primer sequences for the nested PCR to amplify the region around CpG site
cg18562578

CpG Locus ID

cg18562578

Chromosome
Position
(GRCh37/hg19)

Associated
Gene

chr3:55,517,854

Primer Name

Primer Sequence (5’- 3’)

Nested PCR Forward Primer

GATTAAAGGTGTTTTTGATT

Nested PCR Reverse Primer

TCTTTACTTAACCTTTTTATC

WNT5A

Ta

Amplicon
Length
(bp)

49°C

211

Quantitative PCR (qPCR)
A qPCR followed the nested PCR amplification with the design of primers specific to
unmethylated and methylated DNA, respectively. Primers for qPCR had a length between 18-25
bases (Table 2). For this step, two forward primers were designed. One targeting the cg18562578
locus, which served as the methylation-specific primer (target primer) and the second forward
primer was designed to be used as a methylation-independent reference, which complemented a
region away from the CpG site of interest. The 3’ end of the reference primer terminates two bases
before the CpG locus site (Figure 1). The reverse primer used for this assay was the same as the
nested PCR (Table 2). Each primer set was virtually confirmed to produce one specific amplicon
using the BiSearch, ePCR Primer Design, and Search Tool. Design of the selected primer
sequences was completed by ordering the specific forward and reverse sequences through the
online Integrated DNA Technologies (IDT) site.
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Validation and Optimization of Amplification Assays
To confirm the efficiency of the primer design and assays, manufactured control samples were
used. Human HCT116 DKO Methylated DNA and Human HCT116 DKO Non-methylated DNA
(Zymo Research, Catalog, D5014) were used to validate the selected marker and amplification
assays (Figure 2). Both control samples were incorporated to account for fully methylated samples
(HCT116 DKO Methylated DNA) and little to no methylation (Human HCT116 DKO Nonmethylated DNA) at the CpG site of interest.

The bisulfite converted HCT116 DNA controls were processed by following the procedure listed
in section 1.3. They were quantified using the Thermo Scientific™, NanoDrop™ 2000/2000c
Spectrophotometer with 1.0 μL of the sample. The bisulfite converted DNA controls were
quantified using the RNA parameter of the NanoDrop given the DNAs single-stranded, uracil base
incorporated template, which is similar to RNA. Using the determined concentrations, the control
samples were diluted to obtain a concentration of 1.0 ng/µL for the PCR assays.

The nested PCR reaction setup for CpG site cg18562578 was completed using the ZymoTaq™
PreMix (Zymo Research; Catalog, E2003) reagent. The amplification reaction required 6.5 µL of
the polymerase mix accompanied with 0.8 µL of each 5 µM stock of forward and reverse primers,
1.0 μL of 25 millimolar (mM) magnesium chloride with 2.9 µL of nuclease-free water and 1.0 µL
of the diluted 1.0 ng/µL bisulfite converted DNA of control samples. The thermal cycler settings
for the PCR were as follows: initial denaturing 95°C for 10min, 32 cycles of (94°C - 30sec, Ta 35sec, 72°C – 35sec) and a final extension of 72°C for 7min. Annealing temperatures (Ta) specific
to the primer set were determined through independent temperature optimization in increments of
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two degrees plus and minus the optimal salt-adjusted melting temperatures; obtained from the
online Oligo Calc: Oligonucleotide Properties Calculator. The validated annealing temperature
specific to the nested PCR reaction and amplicon sizes, which was checked via electrophoresis on
a 2.0 percent agarose gel, can be found in Table 1.

Amplification of the fragment surrounding marker cg18562578 for both HCT116 fully methylated
and unmethylated DNA controls were successfully processed for the nested PCR reactions and
then diluted 2,000 fold for the quantitative PCR assays. The qPCR step was completed on the
ViiA™ 7 Real-Time PCR System (Thermo Fisher) where 1.0 μL of the diluted product was used
in combination with 5.0 μL of the SsoAdvanced™ Universal SYBR® Green Supermix (BioRad
Catalog, 1725271), 0.4 μL of each 5.0 μM stock of forward and reverse primers, and 3.2 μL of
nuclease-free water to complete a final reaction volume of 10 μL. The controls were run in
duplicates along with non-template controls containing all mentioned reagents except DNA, which
was substituted with 1.0 μL of nuclease-free water. Primer sets specific to the target, and reference
amplifications of the cg18562578 marker were completed independently following appropriate
annealing temperature settings, as detailed in Table 2. Cycling parameters for each amplification
were as follows: initial denaturing: 98°C for 3min, 40 cycles of (95°C - 15sec, Ta - 35sec, 60°C
for 35sec). The qPCR amplification was immediately followed by a melt curve cycle at 65°C/2sec
– 95°C/2sec with 0.5°C ramping.

Determining DNA Methylation Ratios Using Marker cg18562578
The bisulfite converted, nested PCR amplified, Human HCT116 DKO Methylated DNA (fully
methylated) and the Human HCT116 DKO Non-methylated (unmethylated) DNA were both
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normalized to 1.0 ng/uL and combined, varying the volume of each added to account for the
methylation ratios of each standard. Eight standards were created (0.0, 0.1, 0.3, 0.5, 0.7, 0.8, 0.9,
and 1.0). The methylation-specific qPCR was completed using the eight standards, and was
processed in duplicates. The data generated was used to plot a curve of the detected DNA
methylation ratios versus the expected DNA methylation ratios (Figure 3).

Table 2: Locus-specific primer sequences for methylation-specific and methylationindependent qPCR reactions to quantify CpG site cg18562578

Quantitative PCR (qPCR)

cg18562578

CpG
Amplification Forward/
Locus ID
type
Reverse

MethylationSpecific (target)

MethylationIndependent
(reference)

Primer Sequence (5'-3')

Forward

TTTTTTATTAATTAYGGTGC

Reverse

TCTTTACTTAACCTTTTTATC

Forward

GATTTTTTTTTATTAATTAYGGT

Reverse

TCTTTACTTAACCTTTTTATC

Amplicon
Observed Tm
Observed Tm
Calculated Tm Calculated Tm
Length (fully methylated (unmethylated (fully methylated (unmethylated
(bp)
DNA)
DNA)
DNA)
DNA)

Dilution

Ta

2000X

49°C

190

82.2°C

80.4°C

76°C

73°C

2000X

49°C

195

82.3°C

79.4°C

76°C

73°C

Sample Processing
The validated workflow described above and shown in Figure 2 were then applied to the Twin
Identification Epigenetic Study (TIDES) cohort of 332 twin individuals (Figure 2). One thousand
nanograms of genomic DNA from twin samples were processed for bisulfite conversion following
section 1.3. The purified bisulfite-treated DNA was diluted 5-fold (1.0 μL of DNA and 4.0 μL of
nuclease-free water) before the nested PCR amplification. In a 96-well plate, 1.0 μL of the diluted
DNA was used for the amplification of the cg18562578 marker. Each reaction required 6.5 µL of
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the ZymoTaq™ PreMix (Zymo Research; Catalog, E2003) reagent accompanied with 0.8 µL of
a 5 µM stock of forward and reverse primers, 1.0 μL of 25 millimolar (mM) of magnesium
chloride, and 2.9 µL of nuclease-free water. PCR thermal cycler settings were as follows: Initial
denaturing 95°C for 10min, 32 cycles of (94°C - 30sec, Ta - 35sec, 72°C for 35sec) and a final
extension of 72°C for 7min.

Nested PCR products were diluted 2,000 fold for the use in the quantitative PCR assays. The qPCR
step was completed on the ViiA™ 7 Real-Time PCR System (Thermo Fisher) using an optical 384
well plate. 1.0 μL of the diluted product was used for the amplification reaction in combination
with 5.0 μL of the SsoAdvanced™ Universal SYBR® Green Supermix (BioRad, Catalog,
1725271), 0.4 μL of a 5.0 micromolar (μM) stock of forward and reverse primers, and 3.2 μL of
nuclease-free water to complete the 10 μL final reaction volume. Samples were run in duplicates
along with a non-template control containing all reagents mentioned above except DNA and
substitutes with water for each primer set and qPCR run. Primer sets specific to the target, and
reference amplifications of the cg18562578 marker were completed independently following the
appropriate annealing temperatures in Table 2. Cycling parameters for each amplification were as
follows: Initial denaturing: 98°C for 3min, 40 cycles of (95°C - 15sec, Ta for 35sec, 60°C for
35sec). The quantitative amplification was followed by a melt curve cycle at 65°C/2sec –
95°C/2sec with 0.5°C ramping.
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Relative Quantification and Data Analysis
Raw data from the qPCR run was used to quantify the methylation-specific amplification of
cg18562578 using cycle threshold values (Ct). Melt curve peaks and temperatures were evaluated
for confirmation of target-specific amplifications. Relative quantification was then determined by
calculating the 2-ΔΔCt, using the Ct values of the samples and controls (Livak & Schmittgen, 2001).
To obtain 2- ΔΔCt, the differences between two ΔCt’s were calculated to equal ΔΔCt. The first ΔCt
was computed by the difference of the Ct values of the fully methylated control; (Ct fully
methylated control DNA target – Ct fully methylated control DNA reference). The second ΔCt, of the
samples, was calculated in the same manner as the methylated control with respect to the
methylated-specific reaction, and the methylation-independent reaction: (Ct Sample

target

– Ct

Sample reference). The difference between the two ΔCt’s was calculated and used to generate the 2ΔΔCt

for a relative quantification value (DNA methylation ratio) of the given sample with respect

to the fully methylated DNA control.

Relative quantification data calculated by 2- ΔΔCt was further used to determine the success of the
twins by calculating the ratio of the number of twin pairs that generated DNA methylation ratios
and the number of twin pairs provided initially for testing. DNA methylation differences were
determined by subtracting the DNA methylation ratios between each successful twin pair.
Statistical analysis was performed using online tools (https://www.socscistatistics.com/) to
determine normality using the Kolmogorov-Smirnov, and differences between MZ and DZ twins
pairs and twin differences (the mean difference between the twin with the lowest DNA methylation
and the highest DNA methylation within a pair) using the Mann-Whitney tests. p<0.05 were
considered statistically significant for all tests.
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Figure 2: Assay design and experimental flow chart to identify DNA methylation differences
in twins of the TIDES study
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Results and Discussion

Development of a method for the discrimination of MZ twins using DNA Methylation markers

Method development in this research was based on the premise of selecting an epigenetic marker
that was highly discriminative in buccal swab DNA, could be used to differentiate between MZ
twins using a method that accommodated forensic trace-type samples, and could be easily
employed into a forensic laboratory. A method development schematic illustrates the series of
considerations taken in order to design the study (Figure 2).

A comprehensive approach for the discovery of relevant DNA methylation marks starts with a
genome-wide analysis to identify CpG loci. One common methodology to carry out this analysis
is the Illumina Infinium HumanMethylation450 Bead Chip array platform, which allows for the
simultaneous analysis of upwards of 485,000 CpG sites within a single sample. This version of the
Illumina Bead Chip array platform has provided an increase in the RefSeq database genes which
contain nucleotide and protein sequences. There are also multiple CpG sites per gene spreading
across the promoter, 5’ untranslated region, first exon, gene body, and the 3’ untranslated regions
(Pruitt, Tatusova, & Maglott, 2007; Umer & Herceg, 2013). In a study involving the use of this
array platform to identify twin differentially methylated sites using buccal swabs, cigarette butts
and saliva-based DNA 22 molecular markers were discovered amongst a twin pair and further
tested using a qPCR approach that generated data showing twin-to-twin differences greater than
0.1 (Vidaki et al., 2018). From this research, we selected one CpG marker that had the largest DNA
methylation difference between the MZ twin pair by qPCR assay. Differences between twins were
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0.521 for buccal swab DNA, the largest between all markers studied, and 0.412 for cigarette butt
DNA, the second largest difference found in this study (Vidaki et al., 2018). The epigenetic marker
selected, cg18562578 represents a single cytosine at a CpG site (Chr3: 55,517,854) is the identified
target for determining DNA methylation differences between twin pairs (Table 1) (Spector, Bell,
& Spector, 2012).

We developed an assay to determine the DNA methylation status of cg18562578 using a two-step
PCR format. Two DNA controls were used, one fully methylated and one unmethylated, that were
commercially obtained from DNA purified from the human colon cancer cell line, HCT116
(Rajput et al., 2008). The Human HCT116 DKO Methylated DNA (fully methylated) was
enzymatically methylated at all CpG sites. The Human HCT116 DKO Non-methylated DNA
(unmethylated) was extracted from cells that carried genetic knockouts of both DNA
methyltransferases DNMT1 (-/-) and DNMT3B (-/-). The designed nested PCR and qPCR assays
were optimized with the control DNA samples. The initial amplification (nested PCR) product
generated an amplicon of 211bp that was checked on a 2.0% agarose gel (data not shown). Using
the qPCR, we show discrimination between the fully methylated and unmethylated controls
(Figure 3). One reaction was a methylation-specific qPCR using designed primers that targeted the
CpG site of interest (Figure 3A and 3B). Another reaction was a methylation-independent qPCR
with designed primers that were independent of CpG sites (Figure 3C and 3D). Amplification of
the target primer generated a mean cycle threshold difference of 4.16 between the two controls
with the fully methylated control reaching the threshold at the 17th cycle of PCR and the
unmethylated control reached the threshold at the 21st cycle, which represents a DNA methylation
level that is less than that of the methylated control (Figure 3A). Accordingly, the reference
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amplifications generated very close mean Ct values with a difference of only 0.45 (Figure 3C),
showing no differences between DNAs with differential methylation status. We design this method
based on previous research conducted by Vidaki and co-workers (Vidaki et al., 2017). Their
published results showed that for at least one of the markers they amplified the difference in Ct
values between fully methylated and unmethylated controls is of 6.7°C, which is larger than the
difference found by us. However, we can detect a clear pattern in which DNA methylation status
at the site of interest gives a specific amplification profile (Figure 3A) suggesting that our assay
design can identify differential DNA methylation at this site.
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Figure 3: cg18562578 amplification and melt curve plots for the target (methylation-specific)
and reference (methylation independent) qPCR assays using fully methylated DNA (blue)
and unmethylated DNA (green).

Table 3: qPCR values for amplification of cg18562578. Ct and observed/calculated Tm for
target (methylation-specific) and reference (methylation independent)
Molecular Marker cg18562578

Target

Reference

Ct Mean

Ct SD

Mean Tm (°C)

Ct Mean

Ct SD

Mean Tm (°C)

Human HCT116 DKO Methylated DNA

17.130

0.134

82.2

17.386

0.094

82.3

Human HCT116 DKO Non-methylated DNA

21.290

0.018

80.4

17.843

0.083

79.4
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The melt curve assessment correlated with the characteristics of the DNA fragment during the
amplification process. Here, fluorescence detection is recorded as the temperature gradient goes
from 65-95°C, ultimately generating a derivative curve that is characteristic of the DNA
dissociation of the specific DNA fragment amplified. Discrimination of DNA methylation using
bisulfite treatment alters double stranded DNA melting temperatures because unmethylated
cytosines would be modified to uracil bases and later recognized as thymines during the PCR
reaction, while methylated cytosines would remain unchanged (Marqueta-Gracia et al., 2018; Tse
et al., 2011). As a result the fragment amplified using unmethylated DNA would be more A-T rich
and would have a lower melting temperature than a fragment amplified from a fully methylated
sample that is G-C rich. As expected, melt curve plots generate two different melting peaks for the
fully methylated and unmethylated controls (Figure 3B and 3D). A mean temperature difference
of 2.2°C was observed between the methylation-specific reactions of fully and unmethylated
DNAs respectively (Figure 3B and Table 3). This difference was of 2.9°C when the methylationindependent reaction was performed (Figure 3D and Table 3). Here, the melt curves showed one
defined, unique peak in the qPCR assays indicating a specific product was present for each control
DNA tested. We further confirmed our findings by calculating the expected melting temperatures
of the intended targets using the online Science Launcher Oligo Calculator. The 190bp fully
methylated and 195bp unmethylated bisulfite converted DNA sequences were entered into the
Oligo Calculator. The calculated differences between the two control fragments for the target
reactions were 1.8°C and 2.9°C for the reference reactions, which compared to a predicted
difference of 3.0°C is relatively close (Table 3).
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Our study followed a previously published design approach (Vidaki et al., 2017). However, there
are differences between both assays including the investigated genomic region, primer design, and
DNA controls used. These differences could explain how ours and Vidaki and co-workers’ results
differ. In the original design, researchers used a locked nucleic acid (LNA) primer for the
quantification of the methylation specific fragment. Primers containing LNA design allow for
increasing oligonucleotide hybridization strength and specificity. This correlates to stronger
binding efficiencies to the complementary sequences and ultimately results in an increase in the
overall amplification success (Ballantyne, van Oorschot, & Mitchell, 2008). Our initial
experiments suggested that the use of an LNA primer which is more expensive to design, did not
significantly improve the specificity of the methylated-specific amplification and we did not
include it in our study. This could have contributed to the smaller differences in Ct and Tm observed
in our study with the use of a primer set that did not include LNA while performing the developed
2-step PCR method. Nonetheless, our findings confirm that there was a distinction between two
extreme levels of DNA methylation when using the 2-step PCR method.

Linearity of the DNA methylation quantification was tested by using standards of varying DNA
methylation ratios, including 0.0, 0.1, 0.3, 0.5, 0.7, 0.8, 0.9, and 1.0. These standards were
amplified following the 2-step PCR design and using the methylation-specific qPCR. Best-fitted
linearity curves were created by plotting the expected vs the detected DNA methylation ratios
(Figure 5). The results show that there were detectable DNA methylation differences across the
standards. Skewed curves whether above or below the expected line indicated that there is
preferential amplification towards the methylated or unmethylated DNA strand, respectively. In
our case, there is a bias towards the amplification of the methylated DNA for most DNA
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methylation ratio in the range of 0.2-0.7 (Figure 5). PCR bias in DNA methylation analysis can
significantly alter the quantification accuracy (Moskalev et al., 2011). For this assay, the data
points are skewed above the linear curve line suggesting that there was preferential amplification
of the methylated DNA strands (Figure 5). Previous research has found that amplified regions of
template DNA that contain a large number of CpG dinucleotides tend to display more bias
(Warnecke et al., 1997). The region selected for primer design in this assay contained 10 CpG
dinucleotides. After bisulfite conversion the fully methylated control would have kept the 10
cytosines at these positions, while the unmethylated control’s cytosines would be converted to
uracils. In addition, it has been suggested that PCR bias may result from variable methylation
levels of the DNA controls, which are assumed to be 100% (fully methylated) and 0%
(unmethylated) but for which DNA methylation might vary across the genome. Insufficient
bisulfite conversion can also promote bias suggesting more DNA methylation than it actually
exists (Vidaki et al., 2018). Because in our analysis all samples were processed at the same time
using the same reagents and controls, we made no adjustments for the presence of amplification
bias. This allows us to consider our results valid in the discrimination of twin samples. However,
the presence of bias needs to be more carefully considered when implementing an assay like this
in forensic settings in which samples will be processed at different moments and variation in
reagents and laboratory practices can take place.

Research comparing methods used in the investigation of DNA methylation patterns have found
that pyrosequencing is the most consistent and sensitive approach to determine DNA methylation
levels. The study compared pyrosequencing, methylation-specific PCR, MethyLight, and
methylation-sensitive HRM and showed that results by pyrosequencing are also highly correlated
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with the expected percentages of the tested samples (Quillien et al., 2012). Pyrosequencing is
known for being fast, highly qualitative, and has the capability of a single CpG site resolution
(Sabeeha & Hasnain, 2019). However, this methodology is expensive and possibly less practical
for forensic use. Following pyrosequencing, the MethyLight assay has shown the capability of
detecting methylated alleles in the presence of a 10,000-fold excess of unmethylated alleles, and
methylation-sensitive high-resolution melting has distinguished DNA amplified from a
methylation specific PCR containing low levels of methylation (Eads et al., 2000; Rana, 2018).
This method has the drawback that only fully methylated regions are amplified, and this is not
compatible with the selection of one specific CpG site to discriminate within twins, as it was
intended with our design. If future studies describe regions of DNA methylation difference
between MZ twins, methods like MethyLight could be implemented in their discrimination.

In addition, previous work has highlighted the advantages of using a 2-step PCR design suggesting
that this approach has increased sensitivity in comparison to a methylation-specific PCR that leads
to improved detection of methylated DNA sequences (Palmisano et al., 2000). In work by
Palmisano et al, methylated DNA sequences were detected with a 50-fold increase compared to
original methods involving a single methylated allele amongst many unmethylated alleles
(Palmisano et al., 2000). The first step in the 2-step PCR design is the nested PCR, that uses primers
that do not discriminate between methylated or unmethylated alleles. The second PCR is
quantitative and involves the use of primers specific to the methylated or unmethylated DNA
template. In their study, Palmisano and co-workers presented data showing that a single methylated
allele can be detected in the presence of >50,000 unmethylated alleles, which is in line with
increased sensitivity of DNA methylation detection (Palmisano et al., 2000). We applied the same
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approach, and showed that a 2-step PCR is practical for increased detection of DNA methylation
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Figure 4: Linearity curve of DNA methylation quantification of cg18562578.

Discriminating monozygotic twins using a DNA methylation biomarker in buccal swab DNA
Method design and optimization allowed for the application of the 2-step PCR method to
investigate the discriminatory power of marker cg18562578 using DNA methylation within a
cohort of 332 twins. In this study we measured the DNA methylation ratios at the cg18562578 site
in DNA extracted from buccal swabs for each individual in this cohort.
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The applied 2-step PCR methods were successful for 211 of the 332 twin individuals for a 64%
success rate. Of the successful samples, a total of 154 individual samples making 77 twin pairs
were included in the analysis (Table 4). This resulted in an overall 46% success rate. The 77 twin
pairs were further included in statistical analysis to determine whether cg18562578 could be used
to discriminate twins in a pair. Samples were provided in four batches, the success of the samples
of batch 3 and 4 was higher (78%) than the one from batch 1 and 2 (22%), suggesting batch
differences in DNA quality exist and might have impacted the success rate. Because DNA was
extracted in a different setting, we were

not able to account for these differences in our

experiments.

In order to assess such DNA methylation patterns, a discrimination method that can distinguish
between methylated and unmethylated cytosines like bisulfite conversion (BC) is necessary. BC
is considered the gold standard for DNA methylation analysis, providing qualitative, quantitative
and an efficient approach to distinguish methylated and unmethylated cytosines (Leontiou et al.,
2015). Even with the benefit of discriminating between the varying methylation statuses at a given
CpG site, the BC process poses a limitation. The aggressive chemical conditions and high
temperatures cause damage to the genomic DNA template (Grunau, Clark, & Rosenthal, 2001).
BC involves the deamination of unmethylated cytosine bases and occurs in a low pH, using
sulfurous acid, which is required for the protonation of the N3 ring nitrogen to successfully produce
the uracil base. As a result of this, the glycosidic bond that links the DNA bases together tends to
be hydrolyzed near the site of protonation, causing chain breakage (Munson, Clark, LamparskaKupsik, & Smith, 2007). Under the temperature conditions of bisulfite conversion reactions, it has
been found that 84-96% of the DNA gets degraded. Although the conversion efficiencies or DNA
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damage assessments were not evaluated within this study, it is important to note that the potential
DNA damage evidenced in a study evaluating BC kits can affect downstream applications. A
comparison of many bisulfite reaction kits, including the one used in this study, EZ-96 DNA
Methylation-Gold™Kit (Catalog, D5008), has shown that it ranked first for DNA recovery, but
sixth for damage of the DNA when compared to eleven other kits. The integrity of the DNA
samples using this kit showed both high and low quality, but overall had a conversion efficiency
of 99.7% (Kint, De Spiegelaere, De Kesel, Vandekerckhove, & Van Criekinge, 2018). Another
consideration was the fact that saliva-based DNA tends to be co-extracted with bacterial DNA,
and the quantification method used (NanoDrop) was specific to any double-stranded DNA. In the
case of bacterial DNA contamination, it causes a higher concentration reading that results in lower
DNA input in downstream applications such as PCR (Nishitani, Parets, Haas, & Smith, 2018).
With this knowledge, there is a possibility that the DNA recovered after the bisulfite conversion
process may have been fragmented or damaged, or that bacterial DNA might have affected DNA
input into the reaction, which could have prevented successful amplification and explain the low
success (64%) of the 2-step PCR amplification (Table 4). Future work on this cohort would have
to consider these limitations and increase DNA input to guarantee a higher success sample rate.

Table 4: Monozygotic and dizygotic twin sample processing success rates for CpG marker
cg18562578.

Plate

1
2
3
4

Marker

cg18562578
Total

Samples
Processed

Successful
Samples

Sample
Success
Rate

94
90
96
52
332

49
30
82
50
211

52%
33%
85%
96%
-

Sample
Successful
Success of
Twin Sample
Processing
Twin
Twin
Success
Success Individuals
Individuals

64%

18
16
72
48
154

37%
53%
88%
96%
-

46%

CV
(experimental
samples) n=3

52%
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From the original cohort, we were able to measure DNA methylation of cg18562578 in 49 MZ
and 28 DZ pairs with the developed 2-step PCR method. The DNA methylation differences
between twins within a pair were determined by subtracting the ratios between twins in each pair
to calculate the twin difference. The DNA methylation twin difference of MZ and DZ twin pairs
were 0.392±0.296 vs 0.462±0.414, respectively (p-value=0.389) (Figure 5). The lack of a
difference between MZ and DZ twin pair differences suggests that the impact of an identical
genetic background is low and provides support for a potential role of this marker in MZ twin
discrimination. Xu et al., (2015) also compared the DNA methylation differences in MZ and DZ
pairs in a previous study (Xu et al., 2015). In that study, LINE-1 DNA methylation differences
were investigated in three CpG sites of blood and buccal DNA between MZ and DZ twins for
which the authors found there were no statistically significant differences in measurements of
either tissue, blood or saliva (Xu et al., 2015).

Differences between twins were also evaluated by comparing mean values between one twin with
the lowest DNA methylation ratio and the one with the largest ratio. We conducted this analysis
for both MZ and DZ twins. Average DNA methylation ratios were 0.396±0.309 vs 0.785±0.297
(p-value=0.00001) for MZ twins (Figure 6). Average DNA methylation ratios were 0.510±0.332
vs 0.953±0.455 (p-value=0.000128) for DZ twins (Figure 6). The levels of significance is higher
between MZ than DZ twin pair differences, suggesting that ratios of cg18562578 are not impacted
by genetic background. These data further supports the potential for cg18562578 in the
discrimination of MZ twin.
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To better understand the range of DNA methylation differences between MZ twins in our analysis,
we divided samples using previously considered cut-off points for DNA methylation difference
between twins. Three groups resulted from this analysis, one with DNA methylation ratio
differences of less than 0.1, the other one with DNA methylation ratio differences of less than 0.5,
and one including all samples. These data is presented in Figure 7. Differences between twins
remain significant for all samples with a twin difference of less than 0.5, with average DNA
methylation values of 0.481±0.286 vs 0.711±0.293 (p-value=0.001423) between twins. However,
we do not observe a difference between twins in samples in which the twin difference is 0.1 or
less. In this range, average DNA methylation ratios of 0.528±0.272 vs 0.575±0.250 (pvalue=0.338) were observed between twins. We need to consider that as we divide our data into
tertiles we lose power to detect a significant difference between twins, due to a reduction in the
sample size.

There have been five previous studies that investigated differences in DNA methylation between
MZ twin pairs. All of them had a smaller number of twin pairs ranging from 3 to 119. In these
studies the authors used pyrosequencing, qPCR HRM and 2-step PCR approach similar to the one
used here (Marqueta-Gracia et al., 2018; Stewart et al., 2015; Vidaki et al., 2017, 2018; Xu et al.,
2015). Only one of these studies incorporated a large twin sample with 119 MZ and 57 DZ twins
(Xu et al., 2015). In that study, only 15 MZ and 10 DZ twin pairs could be differentiated using
pyrosequencing which represented a success rate of 12% and 17% respectively (Xu et al., 2015).
In our study, we were able to successfully differentiate 77% of the MZ twins pairs, and 82% for
DZ twin pairs. The large twin sample and low success rates observed in the Xu et al., 2015 study
suggests that LINE-1 DNA methylation analysis using the pyrosequencing method may not be a
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feasible approach for MZ twin differentiation (Xu et al., 2015). Another study showed success in
differentiating between twins using a 2-step qPCR method. There, 10 MZ pairs were investigated
using blood-based DNA and comparing forensic trace-type and reference samples. Using low input
trace-type DNA samples, 8 out of the 10 MZ pairs were successfully differentiated. Using a similar
methodology to ours, this study determined that 67.9% of twin pairs with differences >0.1 could
be identified (Vidaki et al., 2017). In comparison we had 38 MZ (77.5%) twin pairs with
differences above 0.1. The similar success rates of both studies supports our finding that a fraction
of twins cannot be easily told apart, because differences in DNA methylation in a specific region
are too small. Vidaki and co-workers also showed that the 2-step PCR method can accommodate
low input samples (Vidaki et al., 2017). While we did not use trace-type samples, we used a similar
approach they did, a methodology designed to increase the chances of amplification of low yield
samples, and we expect using a nested PCR before quantification can support forensic-type sample
quantification. DNA source is important as DNA methylation measures are tissue specific. Buccal
swab DNA was previously investigated in another study including 5 MZ twins. The authors
applied a HRM qPCR method and found that one epigenetic marker had differential DNA
methylation levels in all 5 twin pairs studied (Stewart et al., 2015). Although this study was
successful, their low twin sample does not allow for accurate prediction of success if applied to
another set of samples. Our large cohort of buccal swab samples supports these previous findings
that buccal swab DNA can be used in MZ twin discrimination. Overall, this highlights that our
study is one of the first to have a high success discrimination rate using DNA methylation analysis
in a large twin sample investigating buccal swab DNA.
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Figure 5: cg18562578 DNA methylation average ratio in MZ and DZ twin pairs. Brackets
represent p<0.5
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Figure 6: cg18562578 DNA methylation within pair ratio difference in MZ and DZ twins.
Twin pair DNA methylation ratios of MZ and DZ twins are compared. Brackets represent
p<0.5

43

Figure 7: cg18562578 DNA methylation within pair ratio difference in MZ twins by extent
of difference. Brackets represent p<0.5
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Strengths and Limitations
Strengths of this study include the large twin sample of 129 pairs were MZ and 37 pairs were DZ.
Research involving twins suggest that a large MZ sample set would be necessary to allow for the
understanding of how genetics, the environment, and stochastic effects play a role in epigenetics,
and would allow for the discovery of small epigenetic discoveries (Bell & Spector, 2011; Kratz
et al., 2014). The use of DZ twins in this study is another strength because they are the closest in
genetics and childhood environment. MZ and DZ twins share the same embryonic environment,
birth date, and tend to be exposed to similar environmental factors during early development, and
if one wants to know whether an epigenetic marker can discriminate, DZ twins are the best
comparison group (Bell & Spector, 2011). In this study, we were successful in detecting different
DNA methylation ratios across a large range, which is important because DNA methylation
patterns vary due to different environmental stimuli, resulting in a unique epigenetic fingerprint,
which is the basis for discriminating between MZ twin pairs (Sabeeha & Hasnain, 2019). We also
found that when comparing the MZ and DZ mean DNA methylation differences, they differed
equally regardless of their zygosity, suggesting that the cg18562578 epigenetic marker is at a
highly variable region and is suitable for differentiating between individuals. Also, further
comparison of the MZ twin DNA methylation ratios showed that there were statistically significant
differences between twins 1 and twin 2, which also shows the discriminatory potential of marker
cg18562578.

A limitation in this study stems from the use of reference-type DNA for the effect of trace-type
evidence that generally would be encountered at crime scenes. Although the study by Vidaki et
al., 2017 showed the successful use of trace-type evidence sources under the forensic scenario
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where the DNA yield is on the lower end of the spectrum, there still needs to be more research
incorporating both reference and trace-type samples (Vidaki et al., 2017). Another limitation was
the low success rate and the high coefficient of variation of samples processed over multiple runs.
There was also preferential amplification of the methylated strand during the qPCR assays. In this
case it equally affected all samples as the same methods were applied to process each sample, so
the data generated was still reliable for assessing the discriminatory power of the cg18562578
marker.
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Conclusions and Future Work
Epigenetics has become applicable in forensic science over the years from its first use in sex
determination to body fluid identification, age estimation, and MZ twin differentiation (Vidaki &
Kayser, 2017). In forensic science, the routine STR profiling method poses a limitation, making it
impossible to differentiate between MZ twins because they share identical genomic sequences.
This inability to distinguish between MZ twin pairs has led to research investigating the epigenome
of MZ twins (Bell & Spector, 2011; Copenhaver et al., 2018). Studies have shown that the
epigenome is dynamic and interchangeable in response to environmental stimuli and stochastic
events. Because of this, the epigenome, including DNA modifications, has been used as the basis
for MZ twin differentiation by exploring DNA methylation profiling (Li et al., 2013; Vidaki et al.,
2017, 2018). The application of DNA methylation in forensic science to differentiate between MZ
twins has excellent potential because an individual's DNA regions are uniquely hypomethylated
or hypermethylated (Park et al., 2017).

In this study, an epigenetic molecular marker, cg18562578, previously identified as a twin
differentially methylated marker, was used to design a 2-step PCR method. Careful considerations
in method design led to the successful analysis of 49 MZ and 28 DZ twin pairs, and the successfully
discrimination of 38 MZ pairs yielding a 77% success rate. This is the first study to have this
success rate including a large number of samples.

In future work, kit selection for the bisulfite conversion is going to be of utmost priority to ensure
high conversion efficiencies, high quality, and high DNA yield recovery. Given the potential for
degradation of the DNA template during the conversion process, the amplicon size of the targeted

47
region can be reduced by adjusting the primer design. DNA fragmentation status has been
investigated and tested for fragments ranging from 88-414 base pairs. In some bisulfite conversion
kits, there can be damage to the DNA within this range and therefore can potentially compromise
the intended target region from being amplified efficiently or at all (Kint et al., 2018). There should
also be consideration of other methods that can help to improve the overall success rate, such as
the more expensive MethyLight, TaqMan approach. Another consideration, given that
environmental factors affect DNA methylation patterns, one should survey information such as
age, health, and lifestyle, and categorize the MZ twins in such a way to assess the DNA methylation
differences as a result of these factors. Much work is needed to be completed before such an
epigenetic application is available for implementation into a forensic laboratory, but continued
studies like this contribute to the efforts, progress, and success of this approach.

Overall, this study has shown comparable statistical data of twin-to-twin DNA methylation
differences also seen in similar studies and proves that there is a general feasibility of epigenetic
twin differentiation by applying DNA methylation using a highly discriminative epigenetic
marker, and 2-step PCR method when applied to a large MZ twin sample.
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Appendix 1
DNA methylation differences between successful monozygotic twins
Zygosity

Mean

Standard
Deviation

Range

MZ

0.393

0.296

0.007 - 0.986

Twin 1

Twin 2

0.273
0.406
0.263
0.339
0.010
0.523
1.358
0.033
0.117
1.192
1.007
0.698
0.997
0.467
0.899
0.959
0.023
0.026
1.023
0.657
0.840
0.970
0.885
0.809
0.867
0.923
0.552
0.019
0.737
1.046
0.728
1.070
1.386
0.392
0.326
0.393
0.417
0.915
0.471
0.287
0.947
0.580
0.671
0.019
0.682
0.784
0.777
0.579
0.561

0.006
0.179
0.364
0.007
0.494
0.220
0.413
0.011
0.321
0.689
0.022
0.912
0.632
0.554
0.815
0.018
0.928
0.679
0.257
0.007
0.902
0.001
0.007
0.021
0.354
0.686
0.654
0.391
0.709
0.776
0.711
0.909
0.838
0.833
0.812
0.483
0.698
1.031
0.591
0.381
0.652
0.725
1.091
0.827
0.690
1.224
0.311
1.242
0.967

DNA Methylation
Difference
0.267
0.227
0.101
0.332
0.484
0.303
0.945
0.021
0.204
0.503
0.986
0.214
0.365
0.088
0.083
0.940
0.905
0.653
0.766
0.649
0.062
0.969
0.877
0.789
0.513
0.237
0.102
0.372
0.028
0.270
0.017
0.161
0.548
0.441
0.485
0.090
0.281
0.116
0.120
0.094
0.295
0.145
0.420
0.808
0.007
0.440
0.466
0.663
0.405
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Appendix 2
DNA methylation differences between successful dizygotic twins
Zygosity

Mean

Standard
Deviation

Range

DZ

0.463

0.414

0.002 - 1.694

Twin 1

Twin 2

DNA Methylation
Difference

0.095
0.195
0.270
0.969
0.938
0.876
1.699
0.021
0.545
1.404
0.021
0.623
0.619
0.965
0.729
0.871
0.539
1.254
0.690
0.223
1.084
0.869
0.775
0.712
0.645
1.040
1.106
0.520

0.548
0.267
0.313
1.799
1.026
2.310
0.004
0.446
0.826
0.364
0.804
0.625
0.739
0.407
1.002
0.898
0.651
0.867
0.363
0.688
0.441
0.545
0.429
0.018
0.924
1.145
0.717
1.288

0.453
0.072
0.043
0.829
0.088
1.434
1.694
0.425
0.281
1.040
0.783
0.002
0.120
0.558
0.273
0.027
0.112
0.386
0.327
0.465
0.643
0.323
0.345
0.695
0.280
0.106
0.389
0.768

